Inicure AB
559493-9430ActiveDeveloping novel small molecules to combat resistant bacterial infections effectively.
Overview
- 0
- Employees
- ≤1K SEK
- Revenue
- 2024
- Founded
Key Decision Makers
Peter Olofsson-Sahl
CEO
Johan Bylund
CSO
Sara Malcus
Chair Board of Directors
Felix Sanchez Klose
Researcher — Product Development
Description
Inicure AB is a biotechnology company spun off from Pronoxis AB, established in 2024. The core mission of the organization is to combat the growing global threat of antibiotic resistance. They specialize in developing novel anti-infectious assets based on activating the formyl peptide receptor-1 (FP...
Tags
Keywords
Tech Stack
Company Information
- Industry
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Legal Form
- Aktiebolag
- VAT Number
- SE559493943001
Decision Makers
4 contacts in FunnelfeedrPeter Olofsson-Sahl
CEO
Johan Bylund
CSO
Sara Malcus
Chair Board of Directors
Other Contacts
Felix Sanchez Klose
Researcher — Product Development
Similar Companies
20 similar companies in FunnelfeedrQureTech Bio AB
5–9 employeesDeveloping novel synthetic antibiotics to combat drug-resistant bacteria.
Ribocure Pharmaceuticals AB
20–49 employeesClinical stage biotech developing cutting-edge RNA therapeutics for rare diseases.
Linnane Pharma AB
Developing novel drugs for cancer and infections via proprietary platform.
ProNoxis AB
1 employeesDeveloping small molecule drugs targeting NOX2 activation for inflammation treatment.
SynAct Pharma AB
5–9 employeesClinical-stage biotech resolving inflammation via novel oral therapies.
Browse More
Inicure AB Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo